Quick S - appreciate that we are all different and need to individually assess how effective this product can be and how much revenue it could generate. You have obviously decided it is not for you and that's fine.
However, I was just wondering whether you read the post by Ausmine (#10068371) above.
Imagine the parents of an asthmatic child who they think is OK when the child leaves home for school, for the beach or to play sport, with the parents currently unable to anticipate an attack coming on - just as in Ausmine's case.
It seems to me that, given the unpredictability of the disease, most parents would be happy to pay for an affordable product for the peace of mind it would bring, if they were aware of an accurate predictor of the affliction.
Invest Egate is right onto this and I think the experience of Ausmine will open a lot of people's eyes as to the usefulness and revenue generating possibilities of this product.
ISN Price at posting:
31.5¢ Sentiment: Buy Disclosure: Held